Progesterone is expensive primarily because of how it must be processed to work in your body, the limited competition among brand-name formulations, and the way insurance coverage handles hormone therapies. Brand-name Prometrium runs about $1,820 for a 90-count supply of 100 mg capsules at retail, while even generic micronized progesterone costs around $422 for the same quantity without insurance. Several overlapping factors push these prices up.
The Micronization Process Adds Cost
Your body can’t absorb progesterone well in its natural crystalline form. To make it usable as an oral medication, manufacturers have to grind the hormone into particles smaller than 10 micrometers, a process called micronization. This dramatically increases the surface area of each particle, which improves how quickly it dissolves and gets absorbed in your intestines. The powdered progesterone is then suspended in oil inside a gelatin capsule to further boost absorption.
This isn’t a simple pill-pressing operation. Micronization requires specialized milling equipment, strict quality controls to ensure consistent particle size across every batch, and careful formulation to keep the drug stable in its oil suspension. Newer sustained-release versions use proprietary polymer technology to release progesterone gradually over 16 to 24 hours, adding another layer of manufacturing complexity. Each of these steps adds cost that gets passed along to consumers.
Brand-Name Pricing and the Generic Gap
While the progesterone market technically has many players (a dozen or more companies globally, including Eli Lilly, Novo Nordisk, Teva, and Cipla), that competition hasn’t driven prices down as much as you’d expect. The brand-name version still costs roughly four times what generic capsules cost. Part of the reason is that different formulations serve different purposes: oral capsules, vaginal gels, vaginal inserts, and intramuscular injections each target a specific clinical use, and switching between them isn’t always straightforward.
Some delivery systems no longer have patent protection. The FDA’s vaginal progesterone gel, for instance, appears on the agency’s list of off-patent drugs without an approved generic, meaning no company has brought a generic version to market despite having the legal ability to do so. When generics don’t materialize even after patents expire, prices stay elevated because there’s no cheaper alternative competing for pharmacy shelf space. Filing for FDA approval of a generic still requires significant investment in bioequivalence testing, and if the market for a particular formulation is relatively small, manufacturers may decide the payoff isn’t worth the upfront cost.
Specialty Formulations Cost Significantly More
If you’re using progesterone for fertility treatment rather than general hormone support, the price picture gets worse. Intramuscular progesterone injections remain a mainstay of IVF protocols because they deliver stable, long-lasting blood levels at a relatively lower cost compared to specialty vaginal products. But vaginal gels and inserts, which many patients prefer for comfort and convenience, carry premium pricing because of their specialized delivery technology.
The raw ingredient itself isn’t cheap either. Bulk pharmaceutical-grade progesterone trades at roughly $173,000 per metric ton on international markets, and those prices have been creeping upward. Supply chain tightness, elevated shipping costs, and strong demand from fertility clinics and hormone replacement therapy have all kept upward pressure on the active ingredient’s cost throughout 2025.
Compounding Was Cheaper, Then Regulations Changed
One of the clearest illustrations of how regulation affects progesterone pricing involves a related hormone, 17-hydroxyprogesterone caproate (17P), used to prevent preterm birth. Before the FDA approved a brand-name version called Makena, compounding pharmacies across North Carolina produced 17P for an average of $73 per multi-dose vial. After Makena hit the market at $690 per dose, most compounding pharmacies stopped making it. Out of 18 pharmacies that had been compounding the drug, only 3 continued at the same rate.
Federal rules generally prohibit compounding a drug once an FDA-approved equivalent exists, which effectively removes the cheapest option from the market. The trade-off is quality assurance: not all compounding pharmacies that made 17P regularly tested for purity and potency. But for patients, the practical result is that the affordable version disappears and the brand-name price becomes the only option.
This pattern applies broadly across progesterone products. Compounded progesterone formulations (custom-made creams, capsules, or suppositories) used to offer a budget alternative, but tighter federal oversight of compounding pharmacies has reduced their availability.
Insurance Coverage Is Inconsistent
How much you actually pay depends heavily on your insurance plan, what the progesterone is prescribed for, and which formulation you need. Many insurers cover generic oral progesterone capsules on a standard formulary tier, which can bring your copay down to $10 to $50. But brand-name Prometrium often sits on a higher tier with steeper cost-sharing.
Fertility-related use creates additional headaches. Progesterone prescribed as part of an IVF cycle may fall under your plan’s infertility benefit rather than its standard pharmacy benefit. Some plans, like those administered by UnitedHealthcare, classify injectable fertility drugs separately and may route them through a specialty pharmacy with different cost-sharing rules. In states without infertility coverage mandates, your plan might not cover fertility medications at all, leaving you to pay full retail price out of pocket.
Even when insurance does cover the medication, the form your doctor prescribes matters. Vaginal gels and inserts used in fertility protocols are often classified as specialty drugs, which typically carry the highest copay tier. Intramuscular injections may be covered differently depending on whether they’re administered at a clinic or self-injected at home.
Ways to Reduce Your Cost
If you’re paying out of pocket or facing high copays, generic micronized progesterone capsules are the most affordable oral option at roughly a quarter of the brand-name price. Prescription discount programs can push the price lower still. Intramuscular progesterone in oil, while less convenient than vaginal products, tends to cost less for fertility patients who need sustained luteal support.
Asking your prescriber whether a different formulation could work for your situation is worth the conversation. In some cases, switching from a vaginal gel to oral capsules or from brand-name to generic can save hundreds of dollars per month without compromising effectiveness. For fertility patients, the specific protocol your clinic uses will dictate some of these choices, but there’s often more flexibility than patients realize.